In:
International Journal of Chronic Diseases, Wiley, Vol. 2016 ( 2016), p. 1-7
Abstract:
Background. Using Micral-test (MT) for screening microalbuminuria (MA) among type 2 diabetics (T2D) is helpful. We aimed at determining prevalence of MA and at describing the MT validity. Methods. We studied 182 T2D followed up in family medicine. Two 24-hour urinary quantitative assays of MA had been used as a gold standard. Results . Prevalence of MA was 23%, CI 95%: 16.9–29.1. MT validity was 77% for sensitivity, 88% for negative predictive value, and 0.2 for Kappa coefficient ( p = 0.001 ). Among subjects having a blood pressure ≥130/80 mmHg, having a CHT/HDL ratio ≥ 3, being a T2D for more than 5 years, and being women, negative predictive values were, respectively, 91%, 89%, 95%, and 91%. The area under the ROC curve was 0.81 in men ( p = 0.008 ) and 0.80 when diabetes duration exceeds 5 years ( p = 0.001 ). The MA value at 100% Sp for MT was 35 mg/L. Conclusion. The use of MT in primary healthcare for yearly screening for MA in T2D must be accentuated especially when diabetes duration exceeds 5 years or when associated with other cardiovascular risks.
Type of Medium:
Online Resource
ISSN:
2356-6981
,
2314-5749
DOI:
10.1155/2016/2910627
Language:
English
Publisher:
Wiley
Publication Date:
2016
detail.hit.zdb_id:
2738339-8
Permalink